Search Medical Information
Submit Medical Inquiry Button Field Medical Button Resources Button AEPC Button Pipeline Button
Home
Therapeutic Area
submit medical inquiry
Engage With Field Medical
resources
adverse event & product complaint reporting
pipeline
back
KYNMOBI® (apomorphine hydrochloride)
As of June 30, 2023, Sunovion will voluntarily withdraw Kynmobi® (apomorphine hydrochloride) sublingual film from the U.S. market, due to limited utilization.
Prescribing Information
Patient Information
Instructions for Use
Mechanism of Action and Route of Administration Video
Publications
Overview of Apomorphine
change slide left button
Image for Pshychiatry therapeutic area Conferences
change slide left button